Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1
- PMID: 11850817
- DOI: 10.1038/sj.onc.1205150
Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1
Abstract
Members of the mitogen-activated protein kinase (MAPK) superfamily, including p38 kinase and SAPK/JNK, play a central role in mediating cellular response to environmental stress, growth factors and cytokines. Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine capable of eliciting mitogenic, motogenic and morphogenetic activities in responsive cells, and has been implicated in tumor development and metastasis. Binding of HGF/SF to its tyrosine kinase receptor c-Met stimulates multiple signal transduction pathways, leading to the activation of numerous transcription factors. We here report that HGF/SF can induce cyclin D1 expression in mouse melanoma cells, and that this up-regulation is mediated in part by the activating transcription factor-2 (ATF-2). HGF/SF-mediated phosphorylation of ATF-2 was reduced in the presence of either the p38 kinase-specific inhibitor SB203580, a dominant negative p38 mutant, the SAPK/JNK inhibitor JNK-interacting protein-1 (JIP-1), or the phosphatidylinositol 3-kinase (PI3K)-specific inhibitor LY294002. Activation of p38 kinase by HGF/SF was partially blocked by the PI3K-specific inhibitor as well. The upstream kinases for p38, MKK3/6, did not become activated following HGF/SF exposure, and ATF-2 activation was undiminished by transient transfection of a dominant negative MKK6 mutant. However, transcriptional up-regulation of cyclin D1 by HGF/SF was partially inhibited by the p38 kinase-specific inhibitor, and cyclin D1 protein induction was partially blocked by a dominant negative ATF-2 mutant. Notably, the p38 kinase-specific inhibitor was able to block melanoma cell proliferation but not motility. We conclude that the ATF-2 transcription factor becomes activated by HGF/SF through p38 MAPK and SAPK/JNK. Moreover, the p38-ATF-2 pathway can help mediate proliferation signals in tumor cells through transcriptional activation of key cell cycle regulators.
Similar articles
-
Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2696-704. doi: 10.1167/iovs.03-1371. Invest Ophthalmol Vis Sci. 2004. PMID: 15277494
-
Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.Cancer Res. 2003 Apr 1;63(7):1576-82. Cancer Res. 2003. PMID: 12670907
-
Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.Arthritis Rheum. 2001 Jan;44(1):73-84. doi: 10.1002/1529-0131(200101)44:1<73::AID-ANR11>3.0.CO;2-E. Arthritis Rheum. 2001. PMID: 11212179
-
met and HGF-SF in normal melanocytes and melanoma cells.EXS. 1993;65:329-39. EXS. 1993. PMID: 8380740 Review.
-
Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.Histol Histopathol. 1997 Apr;12(2):537-55. Histol Histopathol. 1997. PMID: 9151142 Review.
Cited by
-
The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process.Genes Cancer. 2010 Mar;1(3):272-82. doi: 10.1177/1947601910365160. Genes Cancer. 2010. PMID: 21779450 Free PMC article.
-
Signal integration by JNK and p38 MAPK pathways in cancer development.Nat Rev Cancer. 2009 Aug;9(8):537-49. doi: 10.1038/nrc2694. Nat Rev Cancer. 2009. PMID: 19629069 Review.
-
[Driver genes and its clinical significance in non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2014 Jun 20;17(6):481-6. doi: 10.3779/j.issn.1009-3419.2014.06.08. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24949689 Free PMC article. Review. Chinese.
-
The status of phosphorylated p38 in esophageal squamous cell carcinoma.Mol Biol Rep. 2012 May;39(5):5315-21. doi: 10.1007/s11033-011-1330-0. Epub 2011 Dec 14. Mol Biol Rep. 2012. PMID: 22167332
-
UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways.Cancer Cell Int. 2021 Feb 4;21(1):88. doi: 10.1186/s12935-021-01768-4. Cancer Cell Int. 2021. PMID: 33632212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous